Bafna Pharmaceuticals Ltd. Share Price & Stock Analysis

Bafna Pharmaceuticals Ltd. (NSE: BAFNAPH, BSE: 532989) is a Chennai, Tamil Nadu-based company in the Pharmaceuticals industry. With a market capitalisation of ₹1,141 Cr, it ranks #1,511 by market cap among the 6,197 Indian listed companies on FinBizNet, and #23 of 63 in Pharmaceuticals. At ₹482.05 (as of 16 Nov 2026), the share price is 3.9% below its 52-week high of ₹501.65 and 386.1% above its 52-week low of ₹99.16. The share price is up 190.0% over one year and up 83.3% over three months.

Key Metrics

Current Price₹482.05
Market Cap₹1,141 Cr
NSE SymbolBAFNAPH
BSE Code532989
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E Ratio104.9
Return on Equity12.27%
Return on Assets4.02%
52-Week Range₹99.16 – ₹501.65
1-Year Price Change+190.0%
3-Month Price Change+83.3%
Beta (1Y)-0.46
HeadquartersChennai, Tamil Nadu
Websitewww.bafnapharma.com

Latest Quarterly Results — Q2 FY27

Revenue₹48 Cr
Net Profit₹7 Cr
Net Margin14.4%
EPS (Basic)₹2.89
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Bafna Pharmaceuticals Ltd. Quarterly Revenue and Profit Trend

Bafna Pharmaceuticals Ltd. reported revenue of ₹48 Cr in Q2 FY27, up 34.4% from ₹35 Cr in Q2 FY26 and up 79.3% from ₹27 Cr in Q1 FY27. It posted a net profit of ₹7 Cr for the quarter, against a net profit of ₹3 Cr in Q2 FY26 (up 119.6%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹27 Cr (Q1 FY27) to ₹48 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹48 Cr₹7 Cr14.4%
Q1 FY27₹27 Cr₹0 Cr0.3%
Q4 FY26₹42 Cr₹3 Cr6.5%
Q3 FY26₹38 Cr₹2 Cr4.8%
Q2 FY26₹35 Cr₹3 Cr8.8%
Q1 FY26₹35 Cr₹3 Cr9.8%
Q4 FY25₹39 Cr₹1 Cr3.4%

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 75.00% of Bafna Pharmaceuticals Ltd.'s shares as of Sept 2026, unchanged from Sept 2025.

About Bafna Pharmaceuticals Ltd.

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, Nigeria, and Commonwealth countries. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited is a subsidiary of SRJR Lifesciences LLP.

Products and Services

1. Pharmaceutical Formulations-This segment manufactures finished pharmaceutical formulations.

Business Segments

1. Manufacturing of Pharmaceuticals Formations,-100%

Bafna Pharmaceuticals Ltd. vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
Bafna Pharmaceuticals Ltd.₹1,141 Cr104.912.27%₹48 Cr+190.0%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Bafna Pharmaceuticals Ltd.?

Bafna Pharmaceuticals Ltd. is trading at ₹482.05, with a market capitalisation of ₹1,141 Cr.

Which sector does Bafna Pharmaceuticals Ltd. belong to?

Bafna Pharmaceuticals Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Bafna Pharmaceuticals Ltd.?

Bafna Pharmaceuticals Ltd. has a P/E of 104.9 and a return on equity of 12.27%.

What is the stock symbol of Bafna Pharmaceuticals Ltd.?

Bafna Pharmaceuticals Ltd. is listed on the NSE under the symbol BAFNAPH and on the BSE under the scrip code 532989.

How has Bafna Pharmaceuticals Ltd.'s share price moved over the past year?

Bafna Pharmaceuticals Ltd.'s share price is up 190.0% over one year and up 83.3% over three months. Its 52-week range is ₹99.16 to ₹501.65.

What were Bafna Pharmaceuticals Ltd.'s latest quarterly results?

In Q2 FY27, Bafna Pharmaceuticals Ltd. reported revenue of ₹48 Cr and net profit of ₹7 Cr, with basic EPS of ₹2.89 (standalone, parsed from the company's exchange filing).

How have Bafna Pharmaceuticals Ltd.'s revenue and profit changed over the past year?

Bafna Pharmaceuticals Ltd. reported revenue of ₹48 Cr in Q2 FY27, up 34.4% from ₹35 Cr in Q2 FY26 and up 79.3% from ₹27 Cr in Q1 FY27.

What is the promoter holding in Bafna Pharmaceuticals Ltd.?

Promoters held 75.00% of Bafna Pharmaceuticals Ltd.'s shares as of Sept 2026, unchanged from Sept 2025.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.